These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10742578)

  • 1. Active growth factor delivery from poly(D,L-lactide-co-glycolide) foams prepared in supercritical CO(2).
    Hile DD; Amirpour ML; Akgerman A; Pishko MV
    J Control Release; 2000 May; 66(2-3):177-85. PubMed ID: 10742578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solvent-free protein encapsulation within biodegradable polymer foams.
    Hile DD; Pishko MV
    Drug Deliv; 2004; 11(5):287-93. PubMed ID: 15742553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of porous microcellular 85/15 poly (DL-lactide-co-glycolide) foams for biomedical applications.
    Singh L; Kumar V; Ratner BD
    Biomaterials; 2004 Jun; 25(13):2611-7. PubMed ID: 14751747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo analysis of macroporous biodegradable poly(D,L-lactide-co-glycolide) scaffolds containing bioactive glass.
    Day RM; Maquet V; Boccaccini AR; Jérôme R; Forbes A
    J Biomed Mater Res A; 2005 Dec; 75(4):778-87. PubMed ID: 16082717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices.
    Hsu YY; Gresser JD; Trantolo DJ; Lyons CM; Gangadharam PR; Wise DL
    J Biomed Mater Res; 1997 Apr; 35(1):107-16. PubMed ID: 9104703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
    Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
    Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of poly(D,L-lactide) and copoly(lactide-glycolide) microspheres of uniform size.
    Shiga K; Muramatsu N; Kondo T
    J Pharm Pharmacol; 1996 Sep; 48(9):891-5. PubMed ID: 8910847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams.
    Lu L; Peter SJ; Lyman MD; Lai HL; Leite SM; Tamada JA; Uyama S; Vacanti JP; Langer R; Mikos AG
    Biomaterials; 2000 Sep; 21(18):1837-45. PubMed ID: 10919687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams by use of ice microparticulates.
    Chen G; Ushida T; Tateishi T
    Biomaterials; 2001 Sep; 22(18):2563-7. PubMed ID: 11516089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material.
    Elgendy HM; Norman ME; Keaton AR; Laurencin CT
    Biomaterials; 1993; 14(4):263-9. PubMed ID: 8386557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copolymerization of D,L-lactide and glycolide in supercritical carbon dioxide with zinc octoate as catalyst.
    Mazarro R; de Lucas A; Gracia I; Rodríguez JF
    J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):196-203. PubMed ID: 17854066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells.
    Kim H; Kim HW; Suh H
    Biomaterials; 2003 Nov; 24(25):4671-9. PubMed ID: 12951010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition.
    Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T
    J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer.
    Isobe M; Yamazaki Y; Oida S; Ishihara K; Nakabayashi N; Amagasa T
    J Biomed Mater Res; 1996 Nov; 32(3):433-8. PubMed ID: 8897149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solvent effects on the microstructure and properties of 75/25 poly(D,L-lactide-co-glycolide) tissue scaffolds.
    Sander EA; Alb AM; Nauman EA; Reed WF; Dee KC
    J Biomed Mater Res A; 2004 Sep; 70(3):506-13. PubMed ID: 15293325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of solvent selection and fabrication method on the characteristics of biodegradable poly(lactide-co-glycolide) microspheres containing ovalbumin.
    Cho SW; Song SH; Choi YW
    Arch Pharm Res; 2000 Aug; 23(4):385-90. PubMed ID: 10976588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam.
    Holy CE; Dang SM; Davies JE; Shoichet MS
    Biomaterials; 1999 Jul; 20(13):1177-85. PubMed ID: 10395386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The formation and characterization of hydrocortisone-loaded poly((+/-)-lactide) microspheres.
    Cavalier M; Benoit JP; Thies C
    J Pharm Pharmacol; 1986 Apr; 38(4):249-53. PubMed ID: 2872287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetracycline-HCl-loaded poly(DL-lactide-co-glycolide) microspheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degradation.
    Bittner B; Mäder K; Kroll C; Borchert HH; Kissel T
    J Control Release; 1999 May; 59(1):23-32. PubMed ID: 10210719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.